CD8A and type 1 diabetes mellitus: Although the induction of CD8+ T-cell exhaustion to mitigate autoimmune destruction of islet β-cells is a highly regarded therapeutic pathway, even if it does not permanently block disease progression in T1DM, it has shown promising effects in mitigating islet β-cell loss (74).